Kalaris Therapeutics Inc (KLRS) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 98.08M | 118.81M | 78.18M | 91.65M | 102.18M | 2.15M | 129.94M | 141.48M | 3.33M | 220.02M | 252.91M | 212.28M |
| Cash & Short-Term Investments | 97.22M | 117.98M | 77M | 88.43M | 100.97M | 1.91M | 129.61M | 140.53M | 3.17M | 213.32M | 246.54M | 202.57M |
| Cash Only | 34.43M | 98.05M | 42.39M | 88.43M | 100.97M | 1.91M | 104.74M | 86.04M | 3.17M | 95.63M | 196.95M | 115.7M |
| Short-Term Investments | 62.79M | 19.93M | 34.61M | 0 | 0 | 0 | 24.87M | 54.49M | 0 | 117.69M | 49.58M | 86.87M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 96K | 181K | 0 | 234K | 106K | 244K |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 861K | 78K | 214K | 228K | 695K | 0 | 230K | 771K | 0 | 5.89M | 4.74M | 7.46M |
| Total Non-Current Assets | 11.73M | 2.93M | 2.99M | 1.19M | 910K | 314K | 1.05M | 2.66M | 0 | 28.29M | 29.78M | 31.77M |
| Property, Plant & Equipment | 1.43M | 1.48M | 1.52M | 0 | 0 | 0 | 495K | 2.11M | 0 | 26.02M | 28.24M | 30.43M |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 8.15M | 499K | 0 | 0 | 0 | 0 | 554K | 554K | 0 | 852K | 852K | 852K |
| Other Non-Current Assets | 2.14M | 953K | 1.48M | 1.19M | 910K | 314K | 0 | 0 | 0 | 1.43M | 684K | 490K |
| Total Assets | 109.81M | 121.74M | 81.17M | 92.84M | 103.09M | 2.46M | 130.99M | 144.14M | 3.33M | 248.31M | 282.69M | 244.04M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 6.51% | - | 3198.46% | -29.12% | -28.48% | -99.01% | -53.66% | -40.94% | -98.8% | -15.45% | 41.35% | 5.61% |
| Total Current Liabilities | 8.08M | 9.71M | 6.07M | 7.65M | 7.14M | 13.77M | 2.36M | 7.66M | 3.94M | 33.07M | 30.56M | 24.96M |
| Accounts Payable | 905K | 1.28M | 494K | 3.68M | 2.37M | 2.23M | 110K | 765K | 2.36M | 3.92M | 5.16M | 4.13M |
| Days Payables Outstanding | 9.84K | 8.16K | - | - | - | - | - | - | - | 114.77 | - | 587.22 |
| Short-Term Debt | 317K | 316K | 0 | 0 | 0 | 9.25M | 667K | 2.29M | 0 | 12.98M | 8.48M | 8.27M |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 6.86M | 6.52M | 1.02M | 686K | 602K | 1.72M | 331K | 2.4M | 540K | 10.91M | 13.21M | 9.92M |
| Current Ratio | 12.14x | 12.23x | 12.89x | 11.98x | 14.31x | 0.16x | 55.08x | 18.48x | 0.85x | 6.65x | 8.28x | 8.50x |
| Quick Ratio | 12.14x | 12.23x | 12.89x | 11.98x | 14.31x | 0.16x | 55.08x | 18.48x | 0.85x | 6.65x | 8.28x | 8.50x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 33.17M | 33.21M | 33.24M | 32.08M | 32.08M | 78.08M | 8.34M | 16.05M | 44.41M | 19.91M | 23.02M | 25.55M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 1.09M | 1.13M | 1.17M | 0 | 0 | 0 | 8.34M | 16.05M | 0 | 19.91M | 23.02M | 25.55M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 32.08M | 32.08M | 32.08M | 32.08M | 32.08M | 78.08M | 0 | 0 | 44.41M | 0 | 0 | 0 |
| Total Liabilities | 41.25M | 42.92M | 39.31M | 39.73M | 39.22M | 91.84M | 10.7M | 23.7M | 48.35M | 52.98M | 53.58M | 50.51M |
| Total Debt | 1.41M | 1.45M | 1.54M | 0 | 0 | 9.25M | 9M | 18.34M | 0 | 32.89M | 31.5M | 33.82M |
| Net Debt | -33.02M | -96.61M | -40.84M | -88.43M | -100.97M | 7.34M | -95.74M | -67.7M | -3.17M | -62.74M | -165.46M | -81.88M |
| Debt / Equity | 0.02x | 0.02x | 0.04x | - | - | - | 0.07x | 0.15x | - | 0.17x | 0.14x | 0.17x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | - | - | - | -6.07x | -45.73x | -10.32x | -42.68x | -88.00x | - | - | - |
| Total Equity | 68.56M | 78.81M | 41.87M | 53.12M | 63.87M | -89.38M | 120.29M | 120.44M | -45.02M | 195.33M | 229.11M | 193.53M |
| Equity Growth % | 7.33% | - | 146.84% | -55.84% | -46.97% | -145.76% | -47.5% | -37.77% | -120.05% | -22.86% | 44.88% | 0.97% |
| Book Value per Share | 2.89 | 3.44 | 2.24 | 2.84 | 15.76 | -17.94 | 24.15 | 24.18 | -9.09 | 39.45 | 55.69 | 47.71 |
| Total Shareholders' Equity | 68.56M | 78.81M | 41.87M | 53.12M | 63.87M | -89.38M | 120.29M | 120.44M | -45.02M | 195.33M | 229.11M | 193.53M |
| Common Stock | 2K | 2K | 2K | 2K | 2K | 0 | 11K | 11K | 0 | 11K | 11K | 9K |
| Retained Earnings | -170.85M | -160M | -150M | -138.11M | -126.76M | -94.53M | -692.57M | -686.49M | -47.39M | -596.5M | -552.23M | -506.96M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -49K | 6K | 6K | 0 | 0 | 0 | -139K | -138K | 0 | -200K | -225K | -301K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |